GW&K Investment Management’s Supernus Pharmaceuticals SUPN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q3 | $51.6M | Sell |
|
|||||
|
2025
Q2 | $39.9M | Sell |
|
|||||
|
2025
Q1 | $45.3M | Buy |
|
|||||
|
2024
Q4 | $43.6M | Sell |
|
|||||
|
2024
Q3 | $38.6M | Sell |
|
|||||
|
2024
Q2 | $34.6M | Sell |
|
|||||
|
2024
Q1 | $45.7M | Buy |
|
|||||
|
2023
Q4 | $38.1M | Sell |
|
|||||
|
2023
Q3 | $38.8M | Buy |
|
|||||
|
2023
Q2 | $42.1M | Sell |
|
|||||
|
2023
Q1 | $51.3M | Buy |
|
|||||
|
2022
Q4 | $50.2M | Sell |
|
|||||
|
2022
Q3 | $59.8M | Sell |
|
|||||
|
2022
Q2 | $55.2M | Buy |
|
|||||
|
2022
Q1 | $59.1M | Sell |
|
|||||
|
2021
Q4 | $53.6M | Buy |
|
|||||
|
2021
Q3 | $43.4M | Buy |
|
|||||
|
2021
Q2 | $49.8M | Buy |
|
|||||
|
2021
Q1 | $41.2M | Buy |
|
|||||
|
2020
Q4 | $33.1M | Buy |
|
|||||
|
2020
Q3 | $21.9M | Buy |
|
|||||
|
2020
Q2 | $18.8M | Buy |
|